{
  "id": 571427,
  "title": "Earnings call transcript: NeurAxis falls on Q2 2026 EPS miss despite 116% revenue growth",
  "url": "https://urgent.news/2026/08/11/earnings-call-transcript-neuraxis-falls-on-q2-2026-eps-miss-despite",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-11T14:13:42.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-neuraxis-falls-on-q2-2026-eps-miss-despite-116-revenue-growth-93CH-4852018"
  },
  "original_language": "en",
  "account": "NeurAxis' Q2 2026 earnings call revealed a loss of $0.19 per share, falling short of the expected $0.16 loss. Despite a 116% surge in revenue to $1.928 million, the medical device maker's shares dropped 6.84% to $6.40 in premarket trading. The company reported its eighth consecutive quarter of double-digit revenue growth. The IB-Stim device was cited as the driver of this growth, as it gained broader reimbursement through a Category I CPT code effective Jan. 1, 2026. Despite the earnings miss, NeurAxis disclosed strong operational progress with revenue more than doubling from the previous year. However, investors focused on the company's ongoing losses and expansion of its commercial footprint. NeurAxis remains in the early commercial phase, with plans to increase insurance coverage, improve market execution, and build its Veterans Affairs business. CEO Brian Carrico highlighted the importance of payer access and commercial execution, while CFO Tim Henrichs noted the rise in operating expenses to support future growth. Analysts expressed interest in the company's discussions with major payers, growth expectations, and the path to profitability. Management emphasized that near-term revenue expectations remain unclear, but they anticipate Q4 to show more sequential growth.",
  "summary": null,
  "key_points": [
    "NeurAxis reported a $0.19 per share loss, missing the expected $0.16 loss",
    "Revenue surged 116% to $1.928 million, driving 8th consecutive quarter of double-digit growth",
    "Shares dropped 6.84% to $6.40 in premarket trading despite strong operational progress"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Earnings call transcript: Consolidated Water tops revenue in Q2 2026, shares rise 7.7%",
        "url": "https://urgent.news/2026/08/11/earnings-call-transcript-consolidated-water-tops-revenue-in-q2-2026",
        "published": "2026-08-11T15:48:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}